Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age. Hsiao A, Yee A, Fireman B, Hansen J, et al. N Engl J Med 2023;389:2245-2255.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hsiao A, Yee A, Fireman B, Hansen J, et al. Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of Age. N Engl J Med 2023;389:2245-2255.
PMID: 38091531